Status:
NOT_YET_RECRUITING
Physical Activity and Sarcoma, Role and Impact on Outcome
Lead Sponsor:
European Institute of Oncology
Conditions:
Sarcoma
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to evaluate the role/impact of physical activity (PA) in sarcomas, in their distribution and potentially also on their prognosis, as already demonstrated for other neoplasms. ...
Detailed Description
The protective role of physical activity (PA) has been demonstrated in numerous diseases, especially cardiovascular and metabolic ones, but also in various neoplastic pathologies. It has been estimat...
Eligibility Criteria
Inclusion
- age \>18;
- diagnose of sarcoma;
- Written informed consent must be signed and dated by the patient and the investigator.
Exclusion
- Kaposi sarcoma.
Key Trial Info
Start Date :
September 30 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 30 2026
Estimated Enrollment :
750 Patients enrolled
Trial Details
Trial ID
NCT06565858
Start Date
September 30 2024
End Date
August 30 2026
Last Update
September 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istituto Europeo di Oncologia
Milan, Italy, 20141